Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort
- PMID: 20131266
- DOI: 10.1002/art.27338
Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort
Abstract
Objective: Despite the recent doubling of the incidence of gout among women and its substantial prevalence particularly in the aging female population, the risk factors for gout among women remain unknown. We undertook this study to evaluate purported risk factors for incident gout among women and to compare them with those among men.
Methods: Using prospective data from the Framingham Heart Study, we examined over a 52-year period (1950-2002) the relationship between purported risk factors and the incidence of gout in 2,476 women and 1,951 men.
Results: We documented 304 incident cases of gout, 104 of them among women. The incidence rates of gout for women per 1,000 person-years according to serum uric acid levels of <5.0, 5.0-5.9, 6.0-6.9, 7.0-7.9, and > or = 8.0 mg/dl were 0.8, 2.5, 4.2, 13.1, and 27.3, respectively (P for trend < 0.0001). The magnitude of this association was lower than that among men (P for interaction = 0.0002). Multivariate relative risks conferred by increasing age (per 5 years), obesity (body mass index > or = 30 kg/m(2)), alcohol intake (> or = 7 ounces of pure alcohol/week), hypertension, and diuretic use were 1.24, 2.74, 3.10, 1.82, and 2.39, respectively (all P < 0.05), for women.
Conclusion: These prospective data with long-term followup provide evidence that higher levels of serum uric acid increase the risk of gout in a graded manner among women, but the rate of increase is lower than that among men. Increasing age, obesity, alcohol consumption, hypertension, and diuretic use were associated with the risk of incident gout among women.
Similar articles
-
The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.J Rheumatol. 2000 Jun;27(6):1501-5. J Rheumatol. 2000. PMID: 10852278
-
The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.J Rheumatol. 2006 Jul;33(7):1346-50. J Rheumatol. 2006. PMID: 16821269
-
Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen.J Rheumatol. 2000 Apr;27(4):1045-50. J Rheumatol. 2000. PMID: 10782835
-
Epidemiology of gout: an update.Best Pract Res Clin Rheumatol. 2010 Dec;24(6):811-27. doi: 10.1016/j.berh.2010.10.004. Best Pract Res Clin Rheumatol. 2010. PMID: 21665128 Review.
-
Serum uric acid and gout: from the past to molecular biology.Curr Med Res Opin. 2013 Apr;29 Suppl 3:3-8. doi: 10.1185/03007995.2013.790800. Curr Med Res Opin. 2013. PMID: 23621555 Review.
Cited by
-
Oral colchicine (colcrys®) in the treatment and prophylaxis of gout†: profile report.Drugs Aging. 2010 Oct 1;27(10):855-7. doi: 10.2165/11206330-000000000-00000. Drugs Aging. 2010. PMID: 20883065 No abstract available.
-
An evaluation of gout visits in the United States for the years 2007 to 2011.BMC Rheumatol. 2018 May 30;2:14. doi: 10.1186/s41927-018-0020-0. eCollection 2018. BMC Rheumatol. 2018. PMID: 30886965 Free PMC article.
-
What Is the Evidence for Treat-to-Target Serum Urate in Gout?Curr Rheumatol Rep. 2018 Mar 8;20(3):11. doi: 10.1007/s11926-018-0719-3. Curr Rheumatol Rep. 2018. PMID: 29516287 Review.
-
Diastolic and systolic blood pressure and gout: a Mendelian randomization study.Front Endocrinol (Lausanne). 2024 May 22;15:1367621. doi: 10.3389/fendo.2024.1367621. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38841306 Free PMC article.
-
Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications.J Clin Med. 2024 Dec 13;13(24):7616. doi: 10.3390/jcm13247616. J Clin Med. 2024. PMID: 39768539 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical